ALS (amyotrophic lateral sclerosis) is a neuro condition that slowly weakens muscle control. For many, hearing “no matching mutation” means a dead end. But not for researcher and advocate Cai Lei 💪.
As of December 2025, Cai leads his team and communicates solely through an eye-tracking device. By locking his gaze on a virtual keyboard, he picks out each letter—turning blinks into powerful messages of hope 👁️✨.
Though he isn’t eligible for Rag-17, a new drug tailored to a specific genetic mutation, Cai hasn’t slowed down. He’s channeling funds into global studies, organizing online care-training workshops for families from Mumbai to Manila, and uniting volunteers to build strong support networks 🌏🤝.
“It’s not about me—it’s about everyone battling ALS,” he shares via his eye-tracker. His determination shows that real impact doesn’t wait for perfect conditions. From crowdfunding a local clinic in Jakarta to sharing caregiving tips in Dhaka, Cai proves that community-driven research can conquer obstacles.
His story reminds us: technology—like eye-tracking, virtual workshops, and digital fundraising—can transform challenges into opportunities. Next time you scroll, consider lending your support—because every share, donation, and word of encouragement matters. Together, we can make a difference 🚀❤️.
Reference(s):
Despite drug mismatch, Cai Lei continues to support ALS research
cgtn.com
